Ranbaxy’s war over generic Lipitor – May. 4, 2011
Pharma
Namenda in the News
Azilsartan Medoxomil (Edarbi)
The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.
TAK-491 would have been a better brand name IMHO.
Statins for Everyone – (not yet)
Doctors should be cautious about prescribing statin drugs for primary prevention in people at low risk of cardiovascular events — because of shortcomings in the evidence to support such use, a Cochrane review warned.
Vorapaxar Phase III Update
Whoops.
The novel antithrombotic vorapaxar causes intracranial hemorrhage in patients with a history of stroke, Merck announced, explaining why stroke survivors were dropped from trials of the experimental drug.
Vilazodone (Viibryd) = New Antidepressant
Medical News: FDA Approves New Antidepressant – in Product Alert, Prescriptions from MedPage Today
Vilazodone (Viibryd) has been approved for treatment of major depression, the FDA announced.
You must be logged in to post a comment.